Revenue: The sum of all revenue fields included for a company's operating activities.
10x Genomics (TXG) had Revenue of $183.98M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$183.98M |
$-48.95M |
|
$68.20M |
|
$115.78M |
|
$239.17M |
|
$-55.19M |
|
$8.59M |
|
$-46.60M |
|
$-46.60M |
|
$-48.95M |
|
$-48.95M |
|
$-48.95M |
|
$-48.95M |
|
$-55.19M |
|
$-43.48M |
|
117.17M |
|
117.17M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$596.02M |
|
$279.57M |
|
$369.12M |
|
$965.14M |
|
$127.16M |
|
-- |
|
$96.94M |
|
$224.10M |
|
$741.04M |
|
$719.92M |
|
$741.04M |
|
119.10M |
|
| Cash Flow Statement Financials | |
$-15.20M |
|
$133.49M |
|
$13.67M |
|
$227.35M |
|
$359.28M |
|
$131.93M |
|
$166.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
62.93% |
|
-30.00% |
|
-30.00% |
|
-- |
|
-25.33% |
|
-26.61% |
|
$-63.80M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.93 |
|
1.60 |
|
56.17 |
|
-6.61% |
|
-6.80% |
|
-5.07% |
|
-6.61% |
|
$6.22 |
|
$-0.54 |
|
$-0.13 |
|